Response to comment on “Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma” and corrigendum

Journal of the Formosan Medical Association 2026 Open access

Read full text

Authors: Ching-Tso Chen, Yu‐Yun Shao

DOI: 10.1016/j.jfma.2026.01.056

Cited by: 0

References: 1

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies

References 1